CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

CCL18; AMAC1; SCYA18; DCCK1; MIP-4; CKb7; Alternative Macrophage Activation Associated CC Chemokine 1; Chemokine C-C-Motif Ligand 18; Macrophage inflammatory protein 4

  • CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC) Packages (Simulation)
  • CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC) Packages (Simulation)
  • CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC) Results demonstration
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

This assay has high sensitivity and excellent specificity for detection of Pulmonary Activation Regulated Chemokine (PARC).
No significant cross-reactivity or interference between Pulmonary Activation Regulated Chemokine (PARC) and analogues was observed.

Recovery of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

Matrices listed below were spiked with certain level of recombinant Pulmonary Activation Regulated Chemokine (PARC) and the recovery rates were calculated by comparing the measured value to the expected amount of Pulmonary Activation Regulated Chemokine (PARC) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-97 92
EDTA plasma(n=5) 91-99 95
heparin plasma(n=5) 78-105 95

Precision of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pulmonary Activation Regulated Chemokine (PARC) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pulmonary Activation Regulated Chemokine (PARC) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pulmonary Activation Regulated Chemokine (PARC) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-97% 97-105% 78-89% 85-94%
EDTA plasma(n=5) 88-101% 86-94% 85-103% 87-95%
heparin plasma(n=5) 96-105% 87-94% 78-88% 87-94%

Stability of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC)

The microplate provided in this kit has been pre-coated with an antibody specific to Pulmonary Activation Regulated Chemokine (PARC). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Pulmonary Activation Regulated Chemokine (PARC). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Pulmonary Activation Regulated Chemokine (PARC) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPB522Hu01 Recombinant Pulmonary Activation Regulated Chemokine (PARC) Positive Control; Immunogen; SDS-PAGE; WB.
APB522Hu01 Active Pulmonary Activation Regulated Chemokine (PARC) Cell culture; Activity Assays.
PAB522Hu01 Polyclonal Antibody to Pulmonary Activation Regulated Chemokine (PARC) WB,IHC
LAB522Hu71 Biotin-Linked Polyclonal Antibody to Pulmonary Activation Regulated Chemokine (PARC) WB; IHC; ICC.
LAB522Hu81 FITC-Linked Polyclonal Antibody to Pulmonary Activation Regulated Chemokine (PARC) WB; IHC; ICC; IF.
MAB522Hu22 Monoclonal Antibody to Pulmonary Activation Regulated Chemokine (PARC) WB; IHC; ICC; IP.
SEB522Hu ELISA Kit for Pulmonary Activation Regulated Chemokine (PARC) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB522Hu CLIA Kit for Pulmonary Activation Regulated Chemokine (PARC) Chemiluminescent immunoassay for Antigen Detection.
LMB522Hu Multiplex Assay Kit for Pulmonary Activation Regulated Chemokine (PARC) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB522Hu01 ELISA Kit DIY Materials for Pulmonary Activation Regulated Chemokine (PARC) Main materials for "Do It (ELISA Kit) Yourself".
GUESTBOOK